miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease

Cheung, 2009, Recent advances in nonalcoholic fatty liver disease, Curr Opin Gastroenterol, 25, 230, 10.1097/MOG.0b013e3283294a18 Canbay, 2004, Apoptosis: the nexus of liver injury and fibrosis, Hepatology, 39, 273, 10.1002/hep.20051 Ferreira, 2011, Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease, Diabetologia, 54, 1788, 10.1007/s00125-011-2130-8 Sayed, 2011, MicroRNAs in development and disease, Physiol Rev, 91, 827, 10.1152/physrev.00006.2010 Cheung, 2008, Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression, Hepatology, 48, 1810, 10.1002/hep.22569 Li, 2009, Differential expression of microRNAs in mouse liver under aberrant energy metabolic status, J Lipid Res, 50, 1756, 10.1194/jlr.M800509-JLR200 Pogribny, 2010, Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice, Lab Invest, 90, 1437, 10.1038/labinvest.2010.113 Hermeking, 2010, The miR-34 family in cancer and apoptosis, Cell Death Differ, 17, 193, 10.1038/cdd.2009.56 Yamakuchi, 2008, MiR-34a repression of SIRT1 regulates apoptosis, Proc Natl Acad Sci USA, 105, 13421, 10.1073/pnas.0801613105 Chang, 2007, Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis, Mol Cell, 26, 745, 10.1016/j.molcel.2007.05.010 Panasiuk, 2006, Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease, World J Gastroenterol, 12, 6198, 10.3748/wjg.v12.i38.6198 Farrell, 2009, Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression, J Gastroenterol Hepatol, 24, 443, 10.1111/j.1440-1746.2009.05785.x Rodrigues, 1998, A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation, J Clin Invest, 101, 2790, 10.1172/JCI1325 Amaral, 2007, P53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis, J Biol Chem, 282, 34250, 10.1074/jbc.M704075200 Castro, 2005, A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid, J Hepatol, 42, 897, 10.1016/j.jhep.2005.01.026 Sola, 2003, Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes, J Biol Chem, 278, 48831, 10.1074/jbc.M300468200 Castro, 2010, Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid, Am J Physiol Gastrointest Liver Physiol, 299, G887, 10.1152/ajpgi.00216.2010 Alisi, 2011, Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease, Lab Invest, 91, 283, 10.1038/labinvest.2010.166 Murakami, 2006, Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues, Oncogene, 25, 2537, 10.1038/sj.onc.1209283 Colak, 2011, SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease, Med Sci Monit, 17, 10.12659/MSM.881749 Audrito, 2011, Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network, Cancer Res, 71, 4473, 10.1158/0008-5472.CAN-10-4452 Chen, 2011, Mir-34a is upregulated during liver regeneration in rats and is associated with the suppression of hepatocyte proliferation, PLoS One, 6, e20238, 10.1371/journal.pone.0020238 Gao, 2011, Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity, J Biol Chem, 286, 22227, 10.1074/jbc.M111.228874 Castro, 2007, Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes, Am J Physiol Gastrointest Liver Physiol, 293, G327, 10.1152/ajpgi.00093.2007 Jin, 2011, Transition from hepatic steatosis to steatohepatitis: unique microRNA patterns and potential downstream functions and pathways, J Gastroenterol Hepatol Cermelli, 2011, Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease, PLoS One, 6, e23937, 10.1371/journal.pone.0023937 Li, 2011, Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1, Mech Ageing Dev, 132, 75, 10.1016/j.mad.2010.12.004 Min, 2012, Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease, Cell Metab, 15, 665, 10.1016/j.cmet.2012.04.004 Benz, 2000, Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes, Eur J Clin Invest, 30, 203, 10.1046/j.1365-2362.2000.00615.x Malhi, 2008, Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease, Semin Liver Dis, 28, 360, 10.1055/s-0028-1091980 Xu, 2010, Lack of SIRT1 (mammalian sirtuin 1) activity leads to liver steatosis in the SIRT1+/− mice: a role of lipid mobilization and inflammation, Endocrinology, 151, 2504, 10.1210/en.2009-1013 Purushotham, 2009, Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation, Cell Metab, 9, 327, 10.1016/j.cmet.2009.02.006 Brooks, 2011, The impact of acetylation and deacetylation on the p53 pathway, Protein Cell, 2, 456, 10.1007/s13238-011-1063-9 Amaral, 2010, Ursodeoxycholic acid modulates the ubiquitin–proteasome degradation pathway of p53, Biochem Biophys Res Commun, 400, 649, 10.1016/j.bbrc.2010.08.121 Lindor, 2004, Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial, Hepatology, 39, 770, 10.1002/hep.20092 Ratziu, 2011, A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis, J Hepatol, 54, 1011, 10.1016/j.jhep.2010.08.030 Tsuchida, 2011, Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-A(y) mice, Metabolism Buko, 2011, Ursodeoxycholic acid dose-dependently improves liver injury in rats fed a methionine- and choline-deficient diet, Hepatol Res, 41, 647, 10.1111/j.1872-034X.2011.00820.x